Search research articles
Contact Us
Filters
Showing results (61-70 of 251) with videos related to
Page
of 26
Sort By:
Drugs
|
June 1, 1990
Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension
H A Friedel, R N Brogden
Drugs
|
September 1, 1990
Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias
J P Monk, R N Brogden
Drugs
|
March 1, 1995
Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria
J C Gillis, R N Brogden
Drugs
|
June 1, 1997
Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients
H D Langtry, R N Brogden
Drugs
|
September 1, 1987
Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use
R N Brogden, R C Heel
Drugs
|
July 1, 1987
l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism
K L Goa, R N Brogden
Drugs
|
July 1, 1985
Guanadrel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension
F A Finnerty, R N Brogden
Drugs
|
March 1, 1988
Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence
J P Gonzalez, R N Brogden
Drugs
|
January 1, 1972
New antibiotics: epicillin, minocycline and spectinomycin a summary of their antibacterial activity, pharmacokinetic properties and therapeutic efficacy
R N Brogden, G S Avery
Drugs
|
March 1, 1990
Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer
J M Henwood, R N Brogden
Page
of 26
Search research articles
Search
Showing results (61-70 of 251) with videos related to
Sort By:
Page
of 26
Drugs
|
June 1, 1990
Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension
H A Friedel, R N Brogden
Drugs
|
September 1, 1990
Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias
J P Monk, R N Brogden
Drugs
|
March 1, 1995
Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria
J C Gillis, R N Brogden
Drugs
|
June 1, 1997
Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients
H D Langtry, R N Brogden
Drugs
|
September 1, 1987
Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use
R N Brogden, R C Heel
Drugs
|
July 1, 1987
l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism
K L Goa, R N Brogden
Drugs
|
July 1, 1985
Guanadrel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension
F A Finnerty, R N Brogden
Drugs
|
March 1, 1988
Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence
J P Gonzalez, R N Brogden
Drugs
|
January 1, 1972
New antibiotics: epicillin, minocycline and spectinomycin a summary of their antibacterial activity, pharmacokinetic properties and therapeutic efficacy
R N Brogden, G S Avery
Drugs
|
March 1, 1990
Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer
J M Henwood, R N Brogden
Page
of 26